Findings Set Stage for Expanded Immunotherapy Role in Bladder Cancer
Researchers now are turning their attention toward earlier disease settings involving patients who are refractory to standard therapies in nonmuscle-invasive bladder cancer or who are poor candidates for surgery in muscle-invasive bladder cancer.
Source: OncLive